Opioid Prescribing Guidelines: Public-Private Partnership Is Tackling Scope, Consequences
US Action Collaborative plans to align guidelines for acute and chronic pain indications; panelist at public meeting questions whether focus should be on pain management rather than opioids.
You may also be interested in...
The US FDA commissioner also suggests the pain medications along with marijuana products should be regulated differently than other drugs.
National Academies of Sciences, Engineering, and Medicine committee meeting suggest it is difficult to write condition-specific guidelines for opioid prescribing in the primary care setting.
The company known for compounding versions of Martin Shkreli’s Daraprim and Allergan’s Restasis is hit with a warning letter for promotions in professional periodicals about its compounded eye drop.